Cohen Charles D, De Blasio Miles J, Farrugia Gabriella E, Dona Malathi S I, Hsu Ian, Prakoso Darnel, Kiriazis Helen, Krstevski Crisdion, Nash David M, Li Mandy, Gaynor Taylah L, Deo Minh, Drummond Grant R, Ritchie Rebecca H, Pinto Alexander R
Cardiac Cellular Systems, Baker Heart and Diabetes Institute, Prahran, VIC, Australia.
Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australia.
iScience. 2023 Aug 28;26(10):107759. doi: 10.1016/j.isci.2023.107759. eCollection 2023 Oct 20.
Diabetes is associated with a significantly elevated risk of heart failure. However, despite extensive efforts to characterize the phenotype of the diabetic heart, the molecular and cellular protagonists that underpin cardiac pathological remodeling in diabetes remain unclear, with a notable paucity of data regarding the impact of diabetes on non-myocytes within the heart. Here we aimed to define key differences in cardiac non-myocytes between spontaneously type-2 diabetic () and healthy control mouse hearts. Single-cell transcriptomic analysis revealed a concerted diabetes-induced cellular response contributing to cardiac remodeling. These included cell-specific activation of gene programs relating to fibroblast hyperplasia and cell migration, and dysregulation of pathways involving vascular homeostasis and protein folding. This work offers a new perspective for understanding the cellular mediators of diabetes-induced cardiac pathology, and pathways that may be targeted to address the cardiac complications associated with diabetes.
糖尿病与心力衰竭风险显著升高相关。然而,尽管人们为描述糖尿病心脏的表型付出了巨大努力,但糖尿病中心脏病理重塑的分子和细胞主角仍不清楚,关于糖尿病对心脏中非心肌细胞影响的数据明显匮乏。在这里,我们旨在确定自发性2型糖尿病()小鼠心脏与健康对照小鼠心脏中非心肌细胞的关键差异。单细胞转录组分析揭示了糖尿病诱导的协同细胞反应,这有助于心脏重塑。这些反应包括与成纤维细胞增生和细胞迁移相关的基因程序的细胞特异性激活,以及涉及血管稳态和蛋白质折叠的信号通路失调。这项工作为理解糖尿病诱导的心脏病理的细胞介质以及可能针对解决与糖尿病相关的心脏并发症的信号通路提供了新的视角。